-
2024-515466-13-00
3
2023-06-28
Glioblastoma multiforme (GBM)
-
2022-502051-56-00
5
2023-04-28
H3 K27M-mutant diffuse glioma
-
2022-501238-52-00
10
2023-03-23
Heart failure due to systemic left ventricular systolic dysfunction
-
2024-510766-16-00
11
2023-03-06
Pancreatoduodenectomy with a high risk for contaminated bile
-
2024-513843-10-00
9
2023-02-28
neuroblastoma
-
2022-502140-13-00
6
2023-01-11
Atrial fibrillation
Acute coronary syndrome
Chronic coronary syndrome
-
2023-507041-28-00
4
2022-11-28
Solid and Hematological Malignancies
-
2023-503679-12-00
1
2022-11-21
Relapsed or Refractory Multiple Myeloma
-
2024-514180-25-00
5
2022-11-21
unresectable or metastatic HER2+ colorectal cancer
-
2023-508389-13-00
5
2022-11-08
Combined endpoint of all-cause mortality, kidney failure, and hospital
-
2023-504885-50-00
5
2022-11-07
Treatment of children with chronic kidney disease and proteinuria
-
2023-509462-38-00
11
2022-10-25
Patients with advanced cancer.
-
2024-511979-15-00
4
2022-10-14
relapsed/refractory Non-Hodgkin Lymphoma
-
2023-508129-28-00
9
2022-09-28
Pediatric patients with Philadelphia chromosome positive chronic myelo
-
2024-515528-35-00
11
2022-09-08
Congenital Haemophilia A
-
2023-503267-42-00
5
2022-06-10
Patients with a histological diagnosis of mismatch- repair deficient h
-
2023-505512-37-00
5
2022-06-07
Acute Myeoloid Leukemia
-
2024-513412-10-00
9
2022-05-11
Anaplastic Large Cell Lymphoma (ALCL)
-
2024-513797-22-00
5
2022-03-09
HER2 positive esophageal adenocarcinoma
-
2023-506945-42-00
1
2022-01-21
Acute myeloid leukaemia
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-510691-20-00
4
2021-09-23
RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced So
-
2023-503435-17-00
5
2021-03-31
Juvenile psoriatic arthritis